‘Serum’s pneumococcal vaccine will be available by June 2020’

Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet to be approved by the DCGI. But phase-3 trial data from Gambia has already been submitted to DCGI and the agency has looked into the data. The Indian phase-3 trial data has now been submitted. … Continue reading ‘Serum’s pneumococcal vaccine will be available by June 2020’

Advertisement

WHO prequalifies Serum’s low-cost pneumococcal vaccine

WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia in Latin America, Africa and Asia. The vaccine will cost only $2 per dose, which is 30% cheaper than the Gavi price. The phase-3 trial data has been submitted to DCGI for licensing. Pneumococcal vaccine … Continue reading WHO prequalifies Serum’s low-cost pneumococcal vaccine